Filing Flows › Elanco Animal Health (ELAN) › Capital expenditures
Elanco Animal Health (ELAN) capital expenditures by quarter
Elanco Animal Health's capital expenditures were $60.0M in Q3 2026 (third quarter 2026), +82% from Q2 2026. Over the last 6 quarters it ranged from $33.0M (Q2 2026) to $92.0M (Q3 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $60.0M | +82% | -35% |
| Q2 2026 | $33.0M | -35% | -42% |
| Q1 2026 | $51.0M | -18% | — |
| Q4 2025 | $62.0M | -33% | — |
| Q3 2025 | $92.0M | +61% | — |
| Q2 2025 | $57.0M | — | — |
Q3 2026 at a glance
Elanco Animal Health, Q3 2026: revenue $1.3B (+11% year over year), operating margin 1.9%, net earnings $18.0M, operating cash flow $216M. The chart follows the revenue to costs, profit and cash.
Questions
What is Elanco Animal Health's capital expenditures?
Elanco Animal Health's capital expenditures were $60.0M in Q3 2026 (third quarter 2026), +82% from Q2 2026.
How has Elanco Animal Health's capital expenditures changed?
Over the last 6 quarters it ranged from $33.0M (Q2 2026) to $92.0M (Q3 2025).